3.Application of Genetic Testing in Individualized Antiplatelet Therapy for Acute Coronary Syndrome Pa-tients after Percutaneous Coronary Intervention
China Pharmacy 2017;28(23):3285-3289
OBJECTIVE:To investigate the value of genetic testing in clopidogrel individualized antiplatelet therapy for acute coronary syndrome(ACS)patients after percutaneous coronary intervention(PCI). METHODS:Clinical pharmacists participated in therapy for 3 ACS patients after PCI,and analyzed risk factors of stent thrombosis as the degree of lesion complexity,length and number of stents,complication,smoking history,etc. Clinical pharmacists suggested conducting clopidogrel genetic testing (CYP2C19,PON1,ACBC1),and suggested replacing antiplatelet agents,maintaining original plan and strengthening monitoring according to the results of genetic testing. RESULTS:The physicians adopted the suggestions of clinical pharmacists. After optimiz-ing antiplatelet therapy according to the results of genetic testing and clinical factors,3 patients were stable and discharged from hospital with drugs. CONCLUSIONS:Genetic testing can provide evidence for the formulation of individualized antiplatelet thera-py in ACS patients after PCI,and can be regarded as one of the breakthrough points for clinical pharmacists to carry out pharmaceu-tical care. In conducting genetic testing,clinical pharmacists should evaluate the risk of thrombosis in ACS patients and select the appropriate population for testing. At the same time,the clinical factors as medication compliance,stent thrombosis risk,therapeu-tic efficacy,ADR,and evidence-based pharmaceutical evidence should be comprehensively evaluated on the basis of genetic test-ing,and antiplatelet therapy plan should be optimized so as to guarantee the safety and effectiveness of drug use.
4.The measurement of thrombomodumin,thrombin-antithrombin and D-dimer in plasma from patients with disseminated intravascular coagulation and its diagnostic significance
Chinese Journal of Primary Medicine and Pharmacy 2005;0(02):-
Objective To analyse the relationship between the diagnosis of disseminated intravascular coagulation(DIC) and the level of Thrombomodumin(TM),thrombin-antithrombin(TAT) and D-dimer in plasma from 67 patients with disseminated intravascular coagulation(DIC).Methods The levels of TM,TAT and D-dimer were measured by a two antibody sandwich enzyme linked immunosorbent assay and a latex aggregation assay.Results The levels of TM,TAT and D-dimer in plasma of patients with DIC were higher than those in control group(P
9.Simple parathyroid adenomectomy through minimal incision for primary hyperparathyroidism caused by single adenoma
Shaoming XU ; Yixiong ZHENG ; Ping WANG
Chinese Journal of General Surgery 2000;0(11):-
ObjectiveTo evaluate the result of direct parathyroid adenomectomy for the treatment of hyperparathyroidism caused by single parathyroid adenoma. MethodsClinical data of 13 cases were retrospectively analyzed from 1993 to 2000. Preoperative Bus, CT, 99mTc-MIBI localization was suggestive of a single adenoma and direct parathyroid adenomectomy through minimal incision was performed.ResultsHyperparathyroidism was cured in all cases. One case underwent second operation in which the pathology found malignancy, making the success rate of simple adenomectomy of 92.3%.Conclusions Simple parathyroid adenomectomy for primary hyper parathyroidism caused by single adenoma is effective?safe alternative to conventional neck exploration should preoperative diagnostic measures verify a single adenoma as the etiology of hyperparathyroidism.
10.Development and Challenge of Health Economics
Xu WEN ; Ping HE ; Xiaoying ZHENG
Chinese Health Economics 2017;36(7):5-8
In recent years,health economics developed quickly,which attracted both international academic and public interested.Compared with the developed countries,although the study of health economics in China started relatively slow,it has already attracted more and more attention by the academic along with the rapidly social development.With the support from international organizations and academic institutions,China had gradually established its health economics research net from 1990s,the research system had been improved and a serious of research achievements had already playedmore important role in the procedure of government decision making.It summarized the research progress in the field of international and China's health economics so as to provide references for research and policies.